Airports for Drones and Flying Taxis Market
Brachytherapy, also known as internal radiation therapy, is a type of radiotherapy in which radiation is delivered directly to a cancerous tumor in the body via a source placed close or next to it. The source emits gamma rays that target cancer cells while minimizing harm to healthy tissue nearby. Depending on the severity of the disease and its damage, brachytherapy is given at a Low Dose Rate (LDR) or a High Dose Rate (HDR). Small radioactive seeds are permanently implanted in or around the tumor in LDR, whereas radioactive sources are removed from the patient’s body at the end of each session in HDR, which is utilized in high-risk tumors.
Brachytherapy Market: Key Players
Argon Medical Devices
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Dickinson and Company
Carl Zeiss Meditec AG
Eckert & Ziegler BEBIG S.A.
Elekta AB, iCAD Inc.
iMedX Information Services
Varian Medical Systems Inc.
Rising prevalence of different types of cancer
Brachytherapy has been shown to be an exceptionally successful treatment choice for cervical, skin, and breast cancers, which is fueling market expansion. Furthermore, the availability of high-quality brachytherapy equipment that delivers precise and very localized radiation doses to tiny tumors has increased patient and medical professional acceptance of the therapy.
Growing medical tourism
Growing medical tourism across the world, as well as increased knowledge of the benefits of brachytherapy, its cost-effectiveness, and higher cure rate when compared to surgery or external beam treatment (EBT), is propelling the industry forward.
High Dose Rate Brachytherapy Devices
Low Dose Rate Brachytherapy Devices
By End User:
Academic Medical Centers
Brachytherapy Market Dynamics
Brachytherapy Market Size
Supply & Demand
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Recent News Related to Market
In 2020, the HDR brachytherapy category led the market, accounting for 71.2 percent of total revenue.
This category is predicted to develop due to the launch of innovative products such as GammaTile for the treatment of brain cancer. IsoRay gained FDA 510K approval for this device in July 2018, which employs Cesium-131 seeds, which have a lower risk of side effects than other regularly used LDR isotopes.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Brachytherapy Market growth?
Which segment accounted for the largest Brachytherapy Market share?
Who are the key players in the Brachytherapy Market?
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Our reports, recent market/vendor-specific changes may take time to reflect in the analysis.